Vogel A, Meyer T, Sapisochin G, Salem R, Saborowski A. Hepatocellular carcinoma. Lancet. 2022;400(10360):1345-62. https://doi.org/10.1016/s0140-6736(22)01200-4.

Article  CAS  PubMed  Google Scholar 

Chan AW, Chan SL, Wong GL, Wong VW, Chong CC, Lai PB et al. Prognostic Nutritional Index (PNI) Predicts Tumor Recurrence of Very Early/Early Stage Hepatocellular Carcinoma After Surgical Resection. Ann Surg Oncol. 2015;22(13):4138-48. https://doi.org/10.1245/s10434-015-4516-1.

Article  PubMed  Google Scholar 

Lv J, Yin H, Mao W, Shi H. Investigating the value of pre-treatment (18)F-FDG PET/CT in predicting the pathological characteristic of hepatocellular carcinoma and recurrence after liver transplantation. Abdom Radiol (NY). 2021;46(6):2490-7. https://doi.org/10.1007/s00261-020-02872-1.

Article  PubMed  Google Scholar 

Hilmi M, Neuzillet C, Calderaro J, Lafdil F, Pawlotsky JM, Rousseau B. Angiogenesis and immune checkpoint inhibitors as therapies for hepatocellular carcinoma: current knowledge and future research directions. J Immunother Cancer. 2019;7(1):333. https://doi.org/10.1186/s40425-019-0824-5.

Article  PubMed  PubMed Central  Google Scholar 

Inayoshi J, Ichida T, Sugitani S, Tsuboi Y, Genda T, Honma N et al. Gross appearance of hepatocellular carcinoma reflects E-cadherin expression and risk of early recurrence after surgical treatment. J Gastroenterol Hepatol. 2003;18(6):673-7. https://doi.org/10.1046/j.1440-1746.2003.03021.x.

Article  PubMed  Google Scholar 

He J, Shi J, Fu X, Mao L, Zhou T, Qiu Y et al. The Clinicopathologic and Prognostic Significance of Gross Classification on Solitary Hepatocellular Carcinoma After Hepatectomy. Medicine (Baltimore). 2015;94(32):e1331. https://doi.org/10.1097/md.0000000000001331.

Article  CAS  PubMed  Google Scholar 

Chernyak V, Fowler KJ, Kamaya A, Kielar AZ, Elsayes KM, Bashir MR et al. Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients. Radiology. 2018;289(3):816-30. https://doi.org/10.1148/radiol.2018181494.

Article  PubMed  Google Scholar 

Kanmaniraja D, Dellacerra G, Holder J, Erlichman D, Chernyak V. Liver Imaging Reporting and Data System (LI-RADS) v2018: Review of the CT/MRI Diagnostic Categories. Can Assoc Radiol J. 2021;72(1):142-9. https://doi.org/10.1177/0846537119888393.

Article  PubMed  Google Scholar 

Rhee H, Chung T, Yoo JE, Nahm JH, Woo HY, Choi GH et al. Gross type of hepatocellular carcinoma reflects the tumor hypoxia, fibrosis, and stemness-related marker expression. Hepatol Int. 2020;14(2):239-48. https://doi.org/10.1007/s12072-020-10012-6.

Article  PubMed  Google Scholar 

Zhang C, Yang R, Wang X, Tao Y, Tang S, Tian Z et al. LI-RADS Morphological Type Predicts Prognosis of Patients with Hepatocellular Carcinoma After Radical Resection. Ann Surg Oncol. 2023;30(8):4876-85. https://doi.org/10.1245/s10434-023-13494-4.

Article  Google Scholar 

Wang T, Li Z, Yu H, Duan C, Feng W, Chang L et al. Prediction of microvascular invasion in hepatocellular carcinoma based on preoperative Gd-EOB-DTPA-enhanced MRI: Comparison of predictive performance among 2D, 2D-expansion and 3D deep learning models. Front Oncol. 2023;13:987781. https://doi.org/10.3389/fonc.2023.987781.

Article  CAS  PubMed  PubMed Central  Google Scholar 

American College of Radiology; CT/MRI LI-RADS® v2018 CORE,2018;[R/OL] https://www.acr.org/-/media/ACR/Files/RADS/LI-RADS/LI-RADS-2018-Core.pdf.

Chow PKH, Gandhi M, Tan SB, Khin MW, Khasbazar A, Ong J et al. SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma. J Clin Oncol. 2018;36(19):1913-21. https://doi.org/10.1200/jco.2017.76.0892.

Article  CAS  PubMed  Google Scholar 

Vilgrain V, Pereira H, Assenat E, Guiu B, Ilonca AD, Pageaux GP et al. Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial. Lancet Oncol. 2017;18(12):1624-36. https://doi.org/10.1016/s1470-2045(17)30683-6.

Article  CAS  PubMed  Google Scholar 

Hack SP, Spahn J, Chen M, Cheng AL, Kaseb A, Kudo M et al. IMbrave 050: a Phase III trial of atezolizumab plus bevacizumab in high-risk hepatocellular carcinoma after curative resection or ablation. Future Oncol. 2020;16(15):975-89. https://doi.org/10.2217/fon-2020-0162.

Article  CAS  PubMed  Google Scholar 

Watanabe T, Tokumoto Y, Joko K, Michitaka K, Horiike N, Tanaka Y et al. AFP and eGFR are related to early and late recurrence of HCC following antiviral therapy. BMC Cancer. 2021;21(1):699. https://doi.org/10.1186/s12885-021-08401-7.

Article  CAS  PubMed Central  Google Scholar 

Regimbeau JM, Abdalla EK, Vauthey JN, Lauwers GY, Durand F, Nagorney DM et al. Risk factors for early death due to recurrence after liver resection for hepatocellular carcinoma: results of a multicenter study. J Surg Oncol. 2004;85(1):36-41. https://doi.org/10.1002/jso.10284.

Article  PubMed  Google Scholar 

Yao LQ, Chen ZL, Feng ZH, Diao YK, Li C, Sun HY et al. Clinical Features of Recurrence After Hepatic Resection for Early-Stage Hepatocellular Carcinoma and Long-Term Survival Outcomes of Patients with Recurrence: A Multi-institutional Analysis. Ann Surg Oncol. 2022. https://doi.org/10.1245/s10434-022-11454-y.

Article  PubMed  PubMed Central  Google Scholar 

Lv T, Zhang B, Xu X, Jiang C, Zheng D, He D et al. Clinical prognosis and related molecular features of hepatitis B-associated adolescent and young adult hepatocellular carcinoma. Hum Genomics. 2023;17(1):52. https://doi.org/10.1186/s40246-023-00500-9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Diao YK, Liu JW, Wu H, Wang MD, Fan XP, Chen TH et al. Long-term oncologic outcomes of liver resection for hepatocellular carcinoma in adolescents and young adults: A multicenter study from a hepatitis B virus-endemic area. Am J Surg. 2021;222(4):751-8. https://doi.org/10.1016/j.amjsurg.2021.03.009.

Article  PubMed  Google Scholar 

She WH, Chan ACY, Cheung TT, Lo CM, Chok KSH. Survival outcomes of liver transplantation for hepatocellular carcinoma in patients with normal, high and very high preoperative alpha-fetoprotein levels. World J Hepatol. 2018;10(2):308-18. https://doi.org/10.4254/wjh.v10.i2.308.

Article  PubMed  Google Scholar 

Deng H, Fan X, Wang X, Zeng L, Zhang K, Zhang X et al. Serum pentraxin 3 as a biomarker of hepatocellular carcinoma in chronic hepatitis B virus infection. Sci Rep. 2020;10(1):20276. https://doi.org/10.1038/s41598-020-77332-3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao WH, Ma ZM, Zhou XR, Feng YZ, Fang BS. Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score. World J Gastroenterol. 2002;8(2):237-42. https://doi.org/10.3748/wjg.v8.i2.237.

Article  PubMed  PubMed Central  Google Scholar 

Yan WT, Li C, Yao LQ, Qiu HB, Wang MD, Xu XF et al. Predictors and long-term prognosis of early and late recurrence for patients undergoing hepatic resection of hepatocellular carcinoma: a large-scale multicenter study. Hepatobiliary Surg Nutr. 2023;12(2):155-68. https://doi.org/10.21037/hbsn-21-288.

Article  PubMed  Google Scholar 

Calderaro J, Ziol M, Paradis V, Zucman-Rossi J. Molecular and histological correlations in liver cancer. J Hepatol. 2019;71(3):616-30. https://doi.org/10.1016/j.jhep.2019.06.001.

Article  CAS  PubMed  Google Scholar 

Jang JY, Kim MY, Jeong SW, Kim TY, Kim SU, Lee SH et al. Current consensus and guidelines of contrast enhanced ultrasound for the characterization of focal liver lesions. Clin Mol Hepatol. 2013;19(1):1-16. https://doi.org/10.3350/cmh.2013.19.1.1.

Article  PubMed  Google Scholar 

Tang A, Bashir MR, Corwin MT, Cruite I, Dietrich CF, Do RKG et al. Evidence Supporting LI-RADS Major Features for CT- and MR Imaging-based Diagnosis of Hepatocellular Carcinoma: A Systematic Review. Radiology. 2018;286(1):29-48. https://doi.org/10.1148/radiol.2017170554.

Article  PubMed  Google Scholar 

Zhou C, Wang Y, Ma L, Qian X, Yang C, Zeng M. Combined hepatocellular carcinoma-cholangiocarcinoma: MRI features correlated with tumor biomarkers and prognosis. Eur Radiol. 2022;32(1):78-88. https://doi.org/10.1007/s00330-021-08188-y.

Article  CAS  PubMed  Google Scholar 

Liu S, Buch S, Chen Y, Choi HS, Dai Y, Habib C et al. Susceptibility-weighted imaging: current status and future directions. NMR Biomed. 2017;30(4). https://doi.org/10.1002/nbm.3552.

Hu K, Wang ZM, Li JN, Zhang S, Xiao ZF, Tao YM. CLEC1B Expression and PD-L1 Expression Predict Clinical Outcome in Hepatocellular Carcinoma with Tumor Hemorrhage. Transl Oncol. 2018;11(2):552-8. https://doi.org/10.1016/j.tranon.2018.02.010.

Article  PubMed  PubMed Central  Google Scholar 

Llovet JM, Peña CE, Lathia CD, Shan M, Meinhardt G, Bruix J. Plasma biomarkers as predictors of outcome in patients with advanced hepatocellular carcinoma. Clin Cancer Res. 2012;18(8):2290-300. https://doi.org/10.1158/1078-0432.Ccr-11-2175.

Article  CAS  PubMed  Google Scholar 

Meng XP, Tang TY, Ding ZM, Wang J, Lu CQ, Yu Q et al. Preoperative Microvascular Invasion Prediction to Assist in Surgical Plan for Single Hepatocellular Carcinoma: Better Together with Radiomics. Ann Surg Oncol. 2022;29(5):2960-70. https://doi.org/10.1245/s10434-022-11346-1.

Article  PubMed  Google Scholar